Creo Medical Group PLC Stock price

Equities

CREO

GB00BZ1BLL44

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 12:35:10 2024-03-28 pm EDT 5-day change 1st Jan Change
34.25 GBX -1.44% Intraday chart for Creo Medical Group PLC -6.80% -25.54%
Sales 2023 * 32.03M 40.43M Sales 2024 * 40.6M 51.24M Capitalization 121M 153M
Net income 2023 * -18M -22.72M Net income 2024 * -11M -13.88M EV / Sales 2023 * 3.09 x
Net cash position 2023 * 22.05M 27.83M Net cash position 2024 * 15.67K 19.78K EV / Sales 2024 * 2.98 x
P/E ratio 2023 *
-6.44 x
P/E ratio 2024 *
-10.8 x
Employees 279
Yield 2023 *
-
Yield 2024 *
-
Free-Float 79.37%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.47%
1 week-6.83%
Current month+15.09%
1 month+15.09%
3 months-17.99%
6 months+12.26%
Current year-25.57%
More quotes
1 week
33.00
Extreme 33
37.45
1 month
29.20
Extreme 29.2
38.00
Current year
29.12
Extreme 29.12
50.00
1 year
22.72
Extreme 22.718
50.00
3 years
19.00
Extreme 19
220.00
5 years
19.00
Extreme 19
243.00
10 years
19.00
Extreme 19
250.00
More quotes
Managers TitleAgeSince
Founder - -
Chief Executive Officer - 11-12-31
President - -
Members of the board TitleAgeSince
Chairman 59 16-06-30
Director/Board Member 60 -
Chief Executive Officer - 11-12-31
More insiders
Date Price Change Volume
24-03-28 34.25 -1.44% 672 267
24-03-27 34.75 -2.11% 199,830
24-03-26 35.5 -2.07% 271,987
24-03-25 36.25 -1.36% 179,295
24-03-22 36.75 0.00% 63,808

Delayed Quote London S.E., March 28, 2024 at 06:56 am EDT

More quotes
Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. It has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes by applying the benefits of advanced laparoscopic surgical technology to areas of therapy where there is significant unmet clinical need. CROMA delivers bipolar radiofrequency energy for precise localized cutting and focused high frequency microwave energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3475 GBP
Average target price
0.995 GBP
Spread / Average Target
+186.33%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Creo Medical Group PLC - London S.E.